Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study
- PMID: 21079138
- PMCID: PMC4809645
- DOI: 10.1200/JCO.2009.27.0090
Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study
Abstract
Purpose: CNS tumors are the most common second primary neoplasm (SPN) observed after childhood cancer in Britain, but the relationship of risk to doses of previous radiotherapy and chemotherapy is uncertain.
Methods: The British Childhood Cancer Survivor Study is a national, population-based, cohort study of 17,980 individuals surviving at least 5 years after diagnosis of childhood cancer. Linkage to national, population-based cancer registries identified 247 SPNs of the CNS. Cohort and nested case-control studies were undertaken.
Results: There were 137 meningiomas, 73 gliomas, and 37 other CNS neoplasms included in the analysis. The risk of meningioma increased strongly, linearly, and independently with each of dose of radiation to meningeal tissue and dose of intrathecal methotrexate. Those whose meningeal tissue received 0.01 to 9.99, 10.00 to 19.99, 20.00 to 29.99, 30.00 to 39.99 and≥40 Gy had risks that were two-fold, eight-fold, 52-fold, 568-fold, and 479-fold, respectively, the risks experienced by those whose meningeal tissue was unexposed. The risk of meningioma among individuals receiving 1 to 39,40 to 69, and at least 70 mg/m2 of intrathecal methotrexate was 15-fold, 11-fold, and 36-fold, respectively, the risk experienced by those unexposed. The standardized incidence ratio for gliomas was 10.8 (95% CI, 8.5 to 13.6). The risk of glioma/primitive neuroectodermal tumors increased linearly with dose of radiation, and those who had CNS tissue exposed to at least 40 Gy experienced a risk four-fold that experienced by those who had CNS tissue unexposed.
Conclusion: The largest-ever study, to our knowledge, of CNS tumors in survivors of childhood cancer indicates that the risk of meningioma increases rapidly with increased dose of radiation to meningeal tissue and with increased dose of intrathecal methotrexate.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Figures
References
-
- Inskip PD Ries LAG Cohen RJ, etal: Curtis RE, Freedman DM, Ron E, et al.New malignancies following childhood cancer New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 465–482,2006. NIH Bethesda, MD: National Cancer Institute; NIH publication 05-5302
-
- Neglia JP Robison LL Stovall M, etal: New Primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the childhood cancer survivor study J Natl Cancer Inst 98:1528–1537,2006 - PubMed
-
- Little MP de Vathaire F Shamsaldin A, etal: Risks of brain tumour following treatment for cancer in childhood: Modification by genetic factors, radiotherapy and chemotherapy Int J Cancer 78:269–275,1998 - PubMed
-
- Goshen Y Stark B Kornreich L, etal: High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia Pediatr Blood Cancer 49:294–297,2007 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
